Related Experiment Video
Updated: Jun 29, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Characterizing the polygenic overlap and shared loci between rheumatoid arthritis and cardiovascular diseases
Xiaohui Sun1, Yu Qian1,2, Weiqiu Cheng3
1Department of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Insights
Rheumatoid arthritis (RA) patients face higher cardiovascular disease (CVD) risks. This study uncovers shared genetic factors between RA and CVD, potentially improving treatment strategies and identifying new drug targets.
Area of Science:
- Genetics
- Cardiology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) patients exhibit increased cardiovascular disease (CVD) morbidity and mortality.
- The underlying mechanisms linking RA and CVD remain incompletely understood.
Purpose of the Study:
- To systematically investigate the phenotypic and genetic correlations between rheumatoid arthritis and cardiovascular diseases.
- To identify shared genetic architecture and potential therapeutic targets.
Main Methods:
- Utilized UK Biobank data for cohort studies on RA and CVD phenotypes (AF, CAD, HF, stroke).
- Employed linkage disequilibrium score regression, Locus Analysis, and bivariate causal mixture models (MiXeR) for genetic correlation analysis.
- Identified shared genetic loci using conjunctional false discovery rate and subset association analyses.
Main Results:
- RA patients demonstrated a significantly higher incidence of CVD (HR=1.21).
- Positive genetic correlations were found between RA and atrial fibrillation (AF) and stroke.
- Identified 23 pleiotropic loci shared between RA and CVD, including a novel locus (rs7098414), with enriched immune, inflammatory, and blood pressure pathways.
Conclusions:
- This research elucidates the shared genetic architecture between rheumatoid arthritis and cardiovascular diseases.
- Findings may guide the identification of novel drug targets and enhance clinical management strategies for RA-CVD comorbidity.
Background:
Despite substantial research revealing that patients with rheumatoid arthritis (RA) have excessive morbidity and mortality of cardiovascular disease (CVD), the mechanism underlying this association has not been fully known. This study aims to systematically investigate the phenotypic and genetic correlation between RA and CVD.
Methods:
Based on UK Biobank, we conducted two cohort studies to evaluate the phenotypic relationships between RA and CVD, including atrial fibrillation (AF), coronary artery disease (CAD), heart failure (HF), and stroke. Next, we used linkage disequilibrium score regression, Local Analysis of [co]Variant Association, and bivariate causal mixture model (MiXeR) methods to examine the genetic correlation and polygenic overlap between RA and CVD, using genome-wide association summary statistics. Furthermore, we explored specific shared genetic loci by conjunctional false discovery rate analysis and association analysis based on subsets.
Results:
Compared with the general population, RA patients showed a higher incidence of CVD (hazard ratio [HR] = 1.21, 95% confidence interval [CI]: 1.15-1.28). We observed positive genetic correlations of RA with AF and stroke, and a mixture of negative and positive local genetic correlations underlying the global genetic correlation for CAD and HF, with 13 ~ 33% of shared genetic variants for these trait pairs. We further identified 23 pleiotropic loci associated with RA and at least one CVD, including one novel locus (rs7098414, TSPAN14, 10q23.1). Genes mapped to these shared loci were enriched in immune and inflammatory-related pathways, and modifiable risk factors, such as high diastolic blood pressure.
Conclusions:
This study revealed the shared genetic architecture of RA and CVD, which may facilitate drug target identification and improved clinical management.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
The JAK-STAT Signaling Pathway
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

